A citation-based method for searching scientific literature

Sakhila Ghimire, Daniela Weber, Emily Mavin, Xiao Nong Wang, Anne Mary Dickinson, Ernst Holler. Front Immunol 2017
Times Cited: 83







List of co-cited articles
497 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.
Madan H Jagasia, Hildegard T Greinix, Mukta Arora, Kirsten M Williams, Daniel Wolff, Edward W Cowen, Jeanne Palmer, Daniel Weisdorf, Nathaniel S Treister, Guang-Shing Cheng,[...]. Biol Blood Marrow Transplant 2015
15

Graft-versus-host disease.
James L M Ferrara, John E Levine, Pavan Reddy, Ernst Holler. Lancet 2009
15

Advances in graft-versus-host disease biology and therapy.
Bruce R Blazar, William J Murphy, Mehrdad Abedi. Nat Rev Immunol 2012
589
14


Mouse models of graft-versus-host disease: advances and limitations.
Mark A Schroeder, John F DiPersio. Dis Model Mech 2011
170
10

The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.
Kenneth R Cooke, Leo Luznik, Stefanie Sarantopoulos, Frances T Hakim, Madan Jagasia, Daniel H Fowler, Marcel R M van den Brink, John A Hansen, Robertson Parkman, David B Miklos,[...]. Biol Blood Marrow Transplant 2017
199
10


The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.
Ying Taur, Robert R Jenq, Miguel-Angel Perales, Eric R Littmann, Sejal Morjaria, Lilan Ling, Daniel No, Asia Gobourne, Agnes Viale, Parastoo B Dahi,[...]. Blood 2014
496
9


National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.
Alexandra H Filipovich, Daniel Weisdorf, Steven Pavletic, Gerard Socie, John R Wingard, Stephanie J Lee, Paul Martin, Jason Chien, Donna Przepiorka, Daniel Couriel,[...]. Biol Blood Marrow Transplant 2005
8

Risk factors for acute GVHD and survival after hematopoietic cell transplantation.
Madan Jagasia, Mukta Arora, Mary E D Flowers, Nelson J Chao, Philip L McCarthy, Corey S Cutler, Alvaro Urbano-Ispizua, Steven Z Pavletic, Michael D Haagenson, Mei-Jie Zhang,[...]. Blood 2012
394
8

Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation.
Robert R Jenq, Carles Ubeda, Ying Taur, Clarissa C Menezes, Raya Khanin, Jarrod A Dudakov, Chen Liu, Mallory L West, Natalie V Singer, Michele J Equinda,[...]. J Exp Med 2012
407
8

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.
Jonathan U Peled, Antonio L C Gomes, Sean M Devlin, Eric R Littmann, Ying Taur, Anthony D Sung, Daniela Weber, Daigo Hashimoto, Ann E Slingerland, John B Slingerland,[...]. N Engl J Med 2020
203
8

Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.
Ernst Holler, Peter Butzhammer, Karin Schmid, Christian Hundsrucker, Josef Koestler, Katrin Peter, Wentao Zhu, Daniela Sporrer, Thomas Hehlgans, Marina Kreutz,[...]. Biol Blood Marrow Transplant 2014
329
8

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
Matthias Edinger, Petra Hoffmann, Joerg Ermann, Kathryn Drago, C Garrison Fathman, Samuel Strober, Robert S Negrin. Nat Med 2003
976
7

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.
Katarina Le Blanc, Ida Rasmusson, Berit Sundberg, Cecilia Götherström, Moustapha Hassan, Mehmet Uzunel, Olle Ringdén. Lancet 2004
7

Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations.
Sumie Fujii, Yasuo Miura, Aya Fujishiro, Takero Shindo, Yutaka Shimazu, Hideyo Hirai, Hidetoshi Tahara, Akifumi Takaori-Kondo, Tatsuo Ichinohe, Taira Maekawa. Stem Cells 2018
101
7

Pathogenesis and management of graft-versus-host disease.
Sung W Choi, John E Levine, James L M Ferrara. Immunol Allergy Clin North Am 2010
107
7

Treatment and management of graft-versus-host disease: improving response and survival.
Catherine Garnett, Jane F Apperley, Jiří Pavlů. Ther Adv Hematol 2013
100
7

Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome.
Daniela Weber, Peter J Oefner, Andreas Hiergeist, Josef Koestler, André Gessner, Markus Weber, Joachim Hahn, Daniel Wolff, Frank Stämmler, Rainer Spang,[...]. Blood 2015
127
7

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.
Andrew C Harris, Rachel Young, Steven Devine, William J Hogan, Francis Ayuk, Udomsak Bunworasate, Chantiya Chanswangphuwana, Yvonne A Efebera, Ernst Holler, Mark Litzow,[...]. Biol Blood Marrow Transplant 2016
255
7



Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.
Kelli P A MacDonald, Geoffrey R Hill, Bruce R Blazar. Blood 2017
153
6

Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia.
Anne M Dickinson, Jean Norden, Shuang Li, Ilona Hromadnikova, Christoph Schmid, Helga Schmetzer, Hans Jochem-Kolb. Front Immunol 2017
93
6

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
Sally Arai, Mukta Arora, Tao Wang, Stephen R Spellman, Wensheng He, Daniel R Couriel, Alvaro Urbano-Ispizua, Corey S Cutler, Andrea A Bacigalupo, Minoo Battiwalla,[...]. Biol Blood Marrow Transplant 2015
214
6

Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease.
John Koreth, Haesook T Kim, Kyle T Jones, Paulina B Lange, Carol G Reynolds, Marie J Chammas, Katherine Dusenbury, Jennifer Whangbo, Sarah Nikiforow, Edwin P Alyea,[...]. Blood 2016
128
6

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.
Katarina Le Blanc, Francesco Frassoni, Lynne Ball, Franco Locatelli, Helene Roelofs, Ian Lewis, Edoardo Lanino, Berit Sundberg, Maria Ester Bernardo, Mats Remberger,[...]. Lancet 2008
6

MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease.
L Kordelas, V Rebmann, A-K Ludwig, S Radtke, J Ruesing, T R Doeppner, M Epple, P A Horn, D W Beelen, B Giebel. Leukemia 2014
609
6


Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.
Robert Zeiser, Nikolas von Bubnoff, Jason Butler, Mohamad Mohty, Dietger Niederwieser, Reuven Or, Jeff Szer, Eva M Wagner, Tsila Zuckerman, Bruyère Mahuzier,[...]. N Engl J Med 2020
230
6

Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT.
E Biagi, D Zama, C Nastasi, C Consolandi, J Fiori, S Rampelli, S Turroni, M Centanni, M Severgnini, C Peano,[...]. Bone Marrow Transplant 2015
79
6

Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation.
Jonathan L Golob, Steven A Pergam, Sujatha Srinivasan, Tina L Fiedler, Congzhou Liu, Kristina Garcia, Marco Mielcarek, Daisy Ko, Sarah Aker, Sara Marquis,[...]. Clin Infect Dis 2017
88
6

Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease.
Robert R Jenq, Ying Taur, Sean M Devlin, Doris M Ponce, Jenna D Goldberg, Katya F Ahr, Eric R Littmann, Lilan Ling, Asia C Gobourne, Liza C Miller,[...]. Biol Blood Marrow Transplant 2015
413
6

Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease.
Alan M Hanash, Jarrod A Dudakov, Guoqiang Hua, Margaret H O'Connor, Lauren F Young, Natalie V Singer, Mallory L West, Robert R Jenq, Amanda M Holland, Lucy W Kappel,[...]. Immunity 2012
395
6

1994 Consensus Conference on Acute GVHD Grading.
D Przepiorka, D Weisdorf, P Martin, H G Klingemann, P Beatty, J Hows, E D Thomas. Bone Marrow Transplant 1995
4

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.
Claudio G Brunstein, Jeffrey S Miller, Qing Cao, David H McKenna, Keli L Hippen, Julie Curtsinger, Todd Defor, Bruce L Levine, Carl H June, Pablo Rubinstein,[...]. Blood 2011
750
4

Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new.
James M Coghill, Stefanie Sarantopoulos, Timothy P Moran, William J Murphy, Bruce R Blazar, Jonathan S Serody. Blood 2011
123
4

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey.
R Zeiser, A Burchert, C Lengerke, M Verbeek, K Maas-Bauer, S K Metzelder, S Spoerl, M Ditschkowski, M Ecsedi, K Sockel,[...]. Leukemia 2015
339
4


Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.
Mauro Di Ianni, Franca Falzetti, Alessandra Carotti, Adelmo Terenzi, Flora Castellino, Elisabetta Bonifacio, Beatrice Del Papa, Tiziana Zei, Roberta Iacucci Ostini, Debora Cecchini,[...]. Blood 2011
767
4

Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease.
Nathan Cantoni, Hans H Hirsch, Nina Khanna, Sabine Gerull, Andreas Buser, Christoph Bucher, Jörg Halter, Dominik Heim, André Tichelli, Alois Gratwohl,[...]. Biol Blood Marrow Transplant 2010
137
4

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.
Michael I Love, Wolfgang Huber, Simon Anders. Genome Biol 2014
4

Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives.
Tomomi Toubai, Nathan D Mathewson, John Magenau, Pavan Reddy. Front Immunol 2016
49
8

Acute Graft Versus Host Disease: A Comprehensive Review.
Samah Nassereddine, Hind Rafei, Ehab Elbahesh, Imad Tabbara. Anticancer Res 2017
88
4

An overview of infectious complications after allogeneic hematopoietic stem cell transplantation.
Ugur Sahin, Selami Kocak Toprak, Pinar Ataca Atilla, Erden Atilla, Taner Demirer. J Infect Chemother 2016
83
4

Current Use and Trends in Hematopoietic Cell Transplantation in the United States.
Anita D'Souza, Stephanie Lee, Xiaochun Zhu, Marcelo Pasquini. Biol Blood Marrow Transplant 2017
157
4

Current issues in chronic graft-versus-host disease.
Gérard Socié, Jerome Ritz. Blood 2014
263
4

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.
M Dominici, K Le Blanc, I Mueller, I Slaper-Cortenbach, Fc Marini, Ds Krause, Rj Deans, A Keating, Dj Prockop, Em Horwitz. Cytotherapy 2006
4



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.